< Back to companies
Leica Biosystems

Leica Biosystems

Washington, DC, US

Leica Biosystems is a global medical device and biotechnology company specializing in clinical diagnostics for the pathology market. They are focused on advancing cancer diagnostics and improving lives by providing comprehensive solutions across the entire pathology workflow, from biopsy to diagnosis.

Share
Shareable draft
Leica Biosystems logo
Get Involved in Leica Biosystems

How We Help

Problem Statement

Leica Biosystems addresses the challenge of providing integrated and efficient solutions across the entire pathology workflow, aiming to advance cancer diagnostics and improve diagnostic accuracy and speed for better patient outcomes.

Core Technology

Digital Pathology (including scanners, software, and AI store), Companion Diagnostics (CDx), Histology Solutions, Pre-Analytics & Specimen Processing, Cytogenetics Imaging Software, and advanced instruments and reagents.

Key Differentiators

Offers a comprehensive, end-to-end portfolio that integrates and optimizes all aspects of the anatomical pathology workflow, connecting departments, solutions, and processes across the cancer diagnosis pathway.

Clinical Focus

Cancer diagnostics

Target Customers

Clinical pathology laboratories, hospitals, and pharmaceutical companies.

Product Stage

Mature

Company Info

Business Model
B2B, providing solutions and technologies across the pathology workflow to laboratories, hospitals, and through partnerships for companion diagnostics with pharmaceutical companies.
Founded
1984
Website
www.leicabiosystems.com

Categories

Drug Discovery/Development

Disease Areas

Technologies

Digital PathologyCompanion DiagnosticsHistologyPre-AnalyticsSpecimen ProcessingCytogenetics Imaging
Only accessible to MedStartr community members. Join now

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of Leica Biosystems?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Leica Biosystems
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free